GSK stock declined 3% despite beating Q1 earnings estimates. Analysts note legal provisions contributed half the beat.
Strong first-quarter results under new GSK CEO Luke Miels on Wednesday failed to impress investors, who raised concerns that ...
A GSK medicine that was pulled from the market after failing its confirmatory test in multiple myeloma has new data from a Phase 3 study evaluating it as an earlier line of treatment, and the latest ...
If you are wondering whether GSK’s current share price really reflects its underlying worth, you are not alone. The stock’s ...
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) and GSK plc (LSE/NYSE: GSK), today announced that the pivotal Phase 3 PIVOT-PO trial evaluating tebipenem HBr ...
GSK plc (NYSE:GSK) on Wednesday agreed to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Under the agreement, GSK will pay up to $2 billion in total cash consideration. This includes ...
GSK plc (NYSE:GSK) ranks among the best low-risk investments in May 2026. GSK plc (NYSE:GSK) stated on April 15 that it had ...
While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case for its first-to-market respiratory syncytial virus (RSV) shot Arexvy. GSK on ...
GSK (GSK) stock is in focus as the company posts better-than-expected financials for Q1 2026 and reaffirms its outlook. Read ...
GSK will use AI, dual sourcing to offset tariff hit Q1 results better-than-expected Shares up 3.8% Maintains 2025 turnover and profit forecasts April 30 (Reuters) - GSK (GSK.L), opens new tab on ...
On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with ...
Mayo Foundation for Medical Education and Research (MFMER) has described glycogen synthase kinase 3 (GSK-3) inhibitors reported to be useful for the treatment of cancer, neurological and psychiatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results